AU2002210887A1 - Methods of and pharmaceutical compositions for improving implantation of embryos - Google Patents

Methods of and pharmaceutical compositions for improving implantation of embryos

Info

Publication number
AU2002210887A1
AU2002210887A1 AU2002210887A AU1088702A AU2002210887A1 AU 2002210887 A1 AU2002210887 A1 AU 2002210887A1 AU 2002210887 A AU2002210887 A AU 2002210887A AU 1088702 A AU1088702 A AU 1088702A AU 2002210887 A1 AU2002210887 A1 AU 2002210887A1
Authority
AU
Australia
Prior art keywords
embryos
methods
pharmaceutical compositions
improving implantation
implantation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210887A
Other languages
English (en)
Inventor
Oron Yacoby-Zeevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insight Strategy and Marketing Ltd
Original Assignee
Insight Strategy and Marketing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Strategy and Marketing Ltd filed Critical Insight Strategy and Marketing Ltd
Publication of AU2002210887A1 publication Critical patent/AU2002210887A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002210887A 2000-10-17 2001-10-15 Methods of and pharmaceutical compositions for improving implantation of embryos Abandoned AU2002210887A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24085700P 2000-10-17 2000-10-17
US60/240,857 2000-10-17
PCT/IL2001/000950 WO2002032283A2 (fr) 2000-10-17 2001-10-15 Procedes et compositions pharmaceutiques pour ameliorer l'implantation d'embryons

Publications (1)

Publication Number Publication Date
AU2002210887A1 true AU2002210887A1 (en) 2002-04-29

Family

ID=22908221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210887A Abandoned AU2002210887A1 (en) 2000-10-17 2001-10-15 Methods of and pharmaceutical compositions for improving implantation of embryos

Country Status (3)

Country Link
EP (1) EP1333862A4 (fr)
AU (1) AU2002210887A1 (fr)
WO (1) WO2002032283A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
CA2432157A1 (fr) * 2000-12-19 2002-06-27 Insight Strategy And Marketing Ltd. Utilisation d'enzymes de degradation de l'ecm en vue de l'amelioration de greffes de cellules
CN100384481C (zh) * 2004-11-03 2008-04-30 上海市计划生育科学研究所 胚泡着床相关因子及其用途
CN100415299C (zh) * 2004-12-22 2008-09-03 上海市计划生育科学研究所 胚泡着床相关因子及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR927003090A (ko) * 1989-08-23 1992-12-17 하다사 메디칼 오르가니제이션 헤파린효소를 포함하는 상처 치유 약제
US5968822A (en) * 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
IL135823A0 (en) * 1997-10-28 2001-05-20 Univ Australian Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor

Also Published As

Publication number Publication date
EP1333862A4 (fr) 2004-08-18
EP1333862A2 (fr) 2003-08-13
WO2002032283A3 (fr) 2002-10-31
WO2002032283A2 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
AU2002226069A1 (en) Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2002319780A1 (en) Alternative compositions and methods for the culture of stem cells
AU2001233081A1 (en) Composition for treatment of stress
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
HU0103078D0 (en) Pharmaceutical compositions and methods for treating cataracts
AU2002212739A1 (en) Compositions for forming bone or periodontium and injections for forming bone orperiodontium
AU2002352533A1 (en) Methods and compositions for treatment of gastric diseases
AUPQ415899A0 (en) Compositions for and methods of treatment of allergic diseases
AU2001271502A1 (en) Methods and compositions for isolating biologically active antibodies
AU7743100A (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AU2001245987A1 (en) Compositions and methods for gene therapy
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU2001288395A1 (en) Method for enhanced delivery of oxybutynin and compositions thereof
WO2001091700A8 (fr) Composition et procede destine a ameliorer l'elasticite des tissus
AU1189201A (en) Therapeutic compositions including protein kinase c inhibitors
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU2001247196A1 (en) Methods and compositions for detection of disease
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU2001251138A1 (en) Compositions and methods for tissue specific gene regulation therapy
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2002210887A1 (en) Methods of and pharmaceutical compositions for improving implantation of embryos